ASSESSING IN-HOSPITAL MORTALITY AND PREDICTORS IN PATIENTS WITH CONTRAST-INDUCED NEPHROPATHY FOLLOWING PRIMARY PERCUTANEOUS CORONARY INTERVENTION
DOI:
https://doi.org/10.55519/JAMC-04-12124Keywords:
Iodinated contrast media, percutaneous coronary intervention (PCI), contrast-induced nephropathy (CIN), mortality, PakistanAbstract
Background: The contrast-induced nephropathy (CIN) is a common complication of primary percutaneous coronary intervention (PCI) it has been reported to be associated with an increased risk of mortality. The study reported the in-hospital mortality among patients who developed CIN after primary PCI. Methods: This descriptive cross-sectional study was conducted on a sample of consecutive who developed CIN after primary PCI at a tertiary care cardiac hospital in Karachi, Pakistan. The CIN was defined as either a relative increase of 25% or an absolute increase of 0.5 mg/dL in post-procedure serum creatinine within 72 hours. The in-hospital mortality status was recorded and clinical and demographic predictors of in-hospital mortality were identified with the help of binary logistic regression analysis. Results: In the study sample of 402 patients, 74.1% (298) were male and the mean age of the study sample was 59.4±11.5 years. The in-hospital mortality rate was 9.7% (39). On multivariable analysis, an increased risk of mortality was found to be independently associated with inferior wall myocardial infarction (IWMI) with right ventricular (RV) infarction, intra-procedure arrhythmias, and pump failure with an adjusted odds ratio of 3.63 [95% CI: 1.31-10.08; p=0.013], 5.53 [95% CI: 1.39-22.06; p=0.015], and 8.94 [95% CI: 3.99-20.02; p<0.001], respectively. Conclusion: In conclusion, there is a high rate of mortality for patients who develop CIN after primary PCI, and the risk of mortality is further aggravated by the presence of IWMI with RV infarction, intra-procedure arrhythmias, and pump failure.References
Khan KA, Kumar R, Shah JA, Farooq F, Shaikh Q, Kumar D, et al. Comparison of angiographic results and clinical outcomes of no-reflow after stenting in left anterior descending (LAD) versus non-LAD culprit STEMI. SAGE Open Med 2022;10:20503121221088106.
Hussain M, Kumar R, Ammar A, Alishan S, Muhammad AS, Farooq F, et al. Frequency of Thrombolysis in Myocardial Infarction III Flow in Patients With Primary Percutaneous Coronary Intervention: Not All Culprit Vessels Are Completely Occluded in ST Elevation Myocardial Infarction. Cureus 2020;12(12):e12036.
Rai L, Kumar R, Raza SA, Batra MK, Mandokhail ZI, Ishaque H, et al. Effect of Coronary Artery Dominance In-terms of Presentation and In-hospital Outcomes of patients undergoing Primary PCI for Culprit Proximal Left Anterior Descending Artery. Pak Heart J 2023;56(1):37–42.
Gallagher S, Knight C. Contrast-induced nephropathy in primary percutaneous coronary intervention. Heart 2011;97(21):1723–5.
He H, Chen XR, Chen YQ, Niu TS, Liao YM. Prevalence and predictors of contrast-induced nephropathy (CIN) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI): a meta-analysis. J Interv Cardiol 2019;2019:2750173.
Kumar R, Ahmed I, Rai L, Khowaja S, Hashim M, Huma Z, et al. Comparative analysis of four established risk scores for prediction of in-hospital mortality in patients undergoing primary percutaneous coronary intervention. Am J Cardiovasc Dis 2022;12(6):298–306.
Kumar R, Memon A, Shaikh A, Huma Z, Kumar V, Hussain A, et al. Timi Risk Index, A Simple Tool In Emergency Percutaneous Revascularization For The Prediction Of Contrast Induced Nephropathy. J Ayub M Coll Abbottabad 2022;34(4):771–7.
Kumar R, Ahmed T, Khatti S, Memon AR, Shaikh NA, Farooq F, et al. Validity of Mehran Risk Score for Predicting Contrast Induced Nephropathy in Modern Primary Percutaneous Coronary Interventions Era. Pak Heart J 2022;55(1):73–8.
Chandiramani R, Cao D, Nicolas J, Mehran R. Contrast-induced acute kidney injury. Cardiovasc Interv ther 2020;35(3):209–17.
Luo M, Zhu Z, Zhang L, Zhang S, You Z, Chen H, et al. Predictive value of N-terminal pro B-type natriuretic peptide for contrast-induced nephropathy non-recovery and poor outcomes among patients undergoing percutaneous coronary intervention. Circ J 2023;87(2):258–65.
Güzel T, Aktan A, Demir M, Özbek M, Aslan B. Relationship between contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in patients with chronic coronary total occlusion. Rev Assoc Med Bras (1992) 2022;68(8):1078–83.
Latif A, Ahsan MJ, Lateef N, Kapoor V, Fazeel HM, Razzaq F, et al. Prognostic Impact of Red Cell Distribution Width on the Development of Contrast-Induced Nephropathy, Major Adverse Cardiac Events, and Mortality in Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention. Curr Cardiol Rev 2021;17(6):e051121191160.
Liu Y, Hong D, Wang AY, Guo R, Smyth B, Liu J, et al. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 2019;19(1):87.
Sun G, Chen P, Wang K, Li H, Chen S, Liu J, et al. Contrast-Induced Nephropathy and Long-Term Mortality After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction. Angiology 2019;70(7):621–6.
Castro-Dominguez YS, Wang Y, Minges KE, McNamara RL, Spertus JA, Dehmer GJ, et al. Predicting in-hospital mortality in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2021;78(3):216–29.
Guo W, Song F, Chen S, Zhang L, Sun G, Liu J, et al. The relationship between hyperuricemia and contrast-induced acute kidney injury undergoing primary percutaneous coronary intervention: secondary analysis protocol for the ATTEMPT RESCIND-1 study. Trials 2020;21(1):567.
Huyut MA. Kidney Injury Molecule-1 Is Associated with Contrast-Induced Nephropathy in Elderly Patients with Non-STEMI. Arq Bras Cardiol 2021;116(6):1048–56.
Yuksel Y, Kose S. Prognostic Nutritional Index Predicts Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome. Angiology 2023;74(8):736–44.
Caspi O, Habib M, Cohen Y, Kerner A, Roguin A, Abergel E, et al. Acute kidney injury after primary angioplasty: is contrast‐induced nephropathy the culprit? J Am Heart Assoc 2017;6(6):e005715.
Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, et al. Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Eng J Med 2021;385(24):2252–63.
Pahuja M, Johnson A, Kabir R, Bhogal S, Wermers JP, Bernardo NL, et al. Randomized Trials of Percutaneous Microaxial Flow Pump Devices: JACC State-of-the-Art Review. J Am Coll Cardiol 2022;80(21):2028–49.
Gao N, Qi XY. Risk factors for in-hospital death in acute ST-segment elevation myocardial infarction after emergency percutaneous coronary intervention: a multicenter retrospective study. Ann Palliat Med 2021;10(11):11756–66.
Gao N, Qi X, Dang Y, Li Y, Wang G, Liu X, et al. Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI. BMC Cardiovasc Disord 2020;20(1):513.
Li Y, Zhou W, Yang L, You R. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacol Res 2020;157:104833.
Additional Files
Published
Issue
Section
License
Copyright (c) 2023 Rajesh Kumar, Kheraj Mal, Abiha Urooj, Barkha Lohana, Mohammad Rasool, Muhammad Yousuf Daud, Kubbra Rahooja, Maryam Samad, Uroosa Safdar, Ali Bin Naseer, Kalsoom Chachar, Muhammad Ishaq, Zahid Ur Rehman, Musa Karim
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
